EcoDrugPlus

Caspase 9

Ensembl ID : ENSOMEG00000008589
Gene Symbol: CASP9
3 Cross references
202 Possible Orthologues:

Catechol-O-Methyltransferase

Ensembl ID : ENSOMEG00000023614
Gene Symbol: COMT
3 Cross references
215 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSOMEG00000002605
Gene Symbol: CTSC
3 Cross references
237 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSOMEG00000017897
Gene Symbol: CTSK
1 Cross references
222 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSOMEG00000013876
Gene Symbol: CTSS
4 Cross references
183 Possible Orthologues:

Cathepsin S-Like

Ensembl ID : ENSOMEG00000000455
Gene Symbol: LOC112136685
3 Cross references
233 Possible Orthologues:

Cell Division Cycle 7 Homolog (S. Cerevisiae)

Ensembl ID : ENSOMEG00000016606
Gene Symbol: CDC7
1 Cross references
207 Possible Orthologues:

Cellular Tumor Antigen P53-Like

Ensembl ID : ENSOMEG00000010516
Gene Symbol: LOC112156259
2 Cross references
232 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSOMEG00000013399
Gene Symbol: CCKAR
4 Cross references
200 Possible Orthologues:

Cholecystokinin Receptor-Like

Ensembl ID : ENSOMEG00000008733
Gene Symbol: LOC112155437
2 Cross references
191 Possible Orthologues:

Cholecystokinin Receptor-Like

Ensembl ID : ENSOMEG00000003473
Gene Symbol: LOC112160085
3 Cross references
193 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSOMEG00000021003
Gene Symbol: LOC112157723
2 Cross references
257 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).